Paper36124682
Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.
Zheng ZZ and 8 others. Nucleic Acids Res, 2022. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer. Papers, record 36124682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36124682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Estrogen Receptor alpha | Major topic |
| Cell Cycle Proteins | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Drug Resistance, Neoplasm | |
| Estrogens | |
| Feedback, Physiological | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Nuclear Proteins | |
| Protein-Tyrosine Kinases | |
| Proto-Oncogene Proteins c-ret | |
| Tamoxifen | |
| Transcription Factors | |
| Bromodomain Containing Proteins |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31765738 | Combinational therapeutic targeting of BRD4 and CDK7 synergistically induces anticancer effects in head and neck squamous cell carcinoma. | Cancer Lett | 2020 | https://conductscience.org/library/papers/31765738 | PubMed |
| 2 | 30529073 | Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma. | Neoplasia | 2019 | https://conductscience.org/library/papers/30529073 | PubMed |
| 3 | 29930091 | Coactivator condensation at super-enhancers links phase separation and gene control. | Science | 2018 | https://conductscience.org/library/papers/29930091 | PubMed |
| 4 | 18483257 | The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer. | Cancer Res | 2008 | https://conductscience.org/library/papers/18483257 | PubMed |
| 5 | 23000897 | Comprehensive molecular portraits of human breast tumours. | Nature | 2012 | https://conductscience.org/library/papers/23000897 | PubMed |
| 6 | 26378038 | Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells. | Oncotarget | 2015 | https://conductscience.org/library/papers/26378038 | PubMed |
| 7 | 11886862 | Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11886862 | PubMed |
| 8 | 32373345 | EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo. | Clin Transl Immunology | 2020 | https://conductscience.org/library/papers/32373345 | PubMed |
| 9 | 21889194 | BET bromodomain inhibition as a therapeutic strategy to target c-Myc. | Cell | 2011 | https://conductscience.org/library/papers/21889194 | PubMed |
| 10 | 33431824 | BRD4-mediated repression of p53 is a target for combination therapy in AML. | Nat Commun | 2021 | https://conductscience.org/library/papers/33431824 | PubMed |
| 11 | 16109377 | Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. | Mol Cell | 2005 | https://conductscience.org/library/papers/16109377 | PubMed |
| 12 | 15013219 | RET and neuroendocrine tumors. | Cancer Lett | 2004 | https://conductscience.org/library/papers/15013219 | PubMed |
| 13 | 25490451 | Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. | Cancer Cell | 2014 | https://conductscience.org/library/papers/25490451 | PubMed |
| 14 | 23868506 | Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells. | EMBO Mol Med | 2013 | https://conductscience.org/library/papers/23868506 | PubMed |
| 15 | 21737465 | Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/21737465 | PubMed |
| 16 | 9539247 | Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. | J Natl Cancer Inst | 1998 | https://conductscience.org/library/papers/9539247 | PubMed |
| 17 | 30621641 | Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer. | BMC Cancer | 2019 | https://conductscience.org/library/papers/30621641 | PubMed |
| 18 | 28446439 | PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. | Cancer Discov | 2017 | https://conductscience.org/library/papers/28446439 | PubMed |
| 19 | 27994038 | Inducible super-enhancers are organized based on canonical signal-specific transcription factor binding elements. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/27994038 | PubMed |
| 20 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42970013 | Super-enhancers: regulatory mechanisms, biological functions, diseases, and therapeutic targets. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42970013 | PubMed |
| 42667172 | Glucose and Glutamine Deprivation Promotes Breast Cancer Lung Metastasis via BRD4-Dependent Enhancer Activation. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42667172 | PubMed |
| 42634815 | Recent Advances (2020-2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies-A Comprehensive Review. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42634815 | PubMed |
| 42464641 | From cell to disease: Regulatory networks and mechanisms of super‑enhancers in aging (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42464641 | PubMed |
| 42332013 | Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42332013 | PubMed |
| 42239905 | BRD4 PROTAC degrader enhances fulvestrant sensitivity in ER+ breast cancer via super-enhancer associated GREB1. | Front Oncol | 2026 | https://conductscience.org/library/papers/42239905 | PubMed |
| 41896222 | Targeting a super-enhancer induced aldehyde dehydrogenase metabolic loop mitigates CDK4/6 inhibitor resistance in estrogen receptor-positive cancers. | Nat Commun | 2026 | https://conductscience.org/library/papers/41896222 | PubMed |
| 41852740 | Optogenetic manipulation of estrogen receptor signaling to improve estrogen deficiency. | iScience | 2026 | https://conductscience.org/library/papers/41852740 | PubMed |
| 41564182 | Superenhancers shape the landscape and repair dynamics of transcription-associated DNA breaks in cancer. | Sci Adv | 2026 | https://conductscience.org/library/papers/41564182 | PubMed |
| 41268574 | Super enhancers as key drivers of gene regulatory networks in normal and malignant hematopoiesis. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41268574 | PubMed |
| 41232326 | Reprogramming oncogenic mitochondria in pancreatic adenocarcinoma through BRD4 inhibition leads to programmed cell death. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/41232326 | PubMed |
| 40966274 | Super-enhancer-associated LINC00963 promotes metastasis of gastric cancer through epithelial-mesenchymal transition. | PLoS One | 2025 | https://conductscience.org/library/papers/40966274 | PubMed |
| 40846852 | Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha. | Nat Commun | 2025 | https://conductscience.org/library/papers/40846852 | PubMed |
| 40713639 | Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies. | J Transl Med | 2025 | https://conductscience.org/library/papers/40713639 | PubMed |
| 40617410 | Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma. | J Adv Res | 2026 | https://conductscience.org/library/papers/40617410 | PubMed |
| 40429758 | Phase Separation: Orchestrating Biological Adaptations to Environmental Fluctuations. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429758 | PubMed |
| 40287441 | MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment. | NPJ Breast Cancer | 2025 | https://conductscience.org/library/papers/40287441 | PubMed |
| 40266891 | Myocardial transcriptomic and proteomic landscapes across the menopausal continuum in a murine model of chemically induced accelerated ovarian failure. | Physiol Genomics | 2025 | https://conductscience.org/library/papers/40266891 | PubMed |
| 40249907 | Zooming into Gene Activation: Estrogen Receptor α Dimerization and DNA Binding Visualized by High-Speed Atomic Force Microscopy. | ACS Nano | 2025 | https://conductscience.org/library/papers/40249907 | PubMed |
| 40240358 | TRAPT: a multi-stage fused deep learning framework for predicting transcriptional regulators based on large-scale epigenomic data. | Nat Commun | 2025 | https://conductscience.org/library/papers/40240358 | PubMed |
Genes45
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36124682
GET https://conductscience.org/api/papers/v1/36124682/references?page=2